A diarrheal disease caused by Cryptoporidium, an intracellular parasite of the phylum Apicomplexa.
Cryptosporidium hominis human genotype 1.
The parasite completes its life cycle in the host, starting with the ingestion of the oocyst forms.
The principle cryptosporidium species that in fact humans are C, parvum and C. hominis.
Molecular techniques are needed to distinguish between the two oocyst species.
Oocysts rupture in the gastrointestinal tract releasing trophozoites, which adhere to and invade epithelial intestinal cells with asexual replication into merozoites.
Merozoites are released into the gastrointestinal lumen and can infect other mucosal cells or differentiate into gametocytes which produce sexually into oocysts restarting the process.
Oocysts are excreted into the feces.
Cryptosporidium is a chlorine resistant parasite and can cause illness after ingestion of as few as 10 oocysts.
Ingestion of oocysts by other hosts spreads the infection.
Spread by person-to-person contact, by infected water, food and animals.
1-2 cases per 100,000 population in the U.S. reported each year.
Spread by fecal-oral contact from oral-anal contact or poor hygiene and by fomites.
Infected ingested or recreational water a major source of outbreaks of infection.
Oocysts are hardy and require few to initiate infection.
Oocysts can be infectious for up to 6 months, if kept moist.
Oocysts are unaffected by chlorine treated water.
Can survive for days in recreational waters such as swimming pools and water parks.
Fecal-oral transmission of Cryptosporidium oocysts can occur via ingestion of contaminated recreational water, drinking water, or food, or through contact with infected persons or animals, most notably preweaned calves.
Treatment of water with filters, ultraviolet radiation and ozone required to remove or kill the parasitic organisms.
Primarily a gastrointestinal disease manifested by diarrhea.
Watery diarrhea lasts 1-3 weeks.
A self limited illness in immunocompetent patients.
Effects immunocompetent and immunocompromised individuals especially those with HIV.
It affects immunocompetent, mostly children under the age of five.
In immune competent persons the disease can range from asymptomatic infection to diarrhea that typically lasts 1 to 2 weeks.
Immunocompromised individuals may experience chronic and severe diarrhea which can lead to weight loss, malnutrition and potentially death.
In immunodeficient individuals, particularly in HIV patients, can be a life-threatening process.
Prevalence decreasing with the addition of highly active antiretroviral therapy.
Prior to the use of HAART 3-4% of patients with AIDS contracted this infection.
HAART therapy that improves CD4 count reduces the severity of the infection, but is not curative and the symptoms can remit when immune status worsens.
To control transmission hand washing with soap and using disposable towels or air dryers.
Alcohol-based hand sanitizes are not effective against Cryptosporidium.
Contact with preweaned calves should be limited.
Paromomycin, atovaquone, nitazoxanide,and azithromycin have only temporary effects.
Treatment is primarily supportive, and intravenous fluids may rarely be needed.
Antibiotics are not usually helpful, and are primarily reserved for persons with severe disease and immunosuppression.
Nitazoxamide an antiparasitic agent has been shown to be efficacious in immunocompetent patients.